February 21st – Dr. Stanley Fisher

Living Well With PD: Understanding Parkinson’s Disease and Current Treatments
Stanley Fisher, M.D.

Dr. Stanley Fisher

Dr. Stanley Fisher is our featured presenter for our February meeting. Founder and Co-Director of the Movement Disorders and Neurorehabilitation Center at Methodist Neurological Institute and Associate Professor of Neurology at Weill Cornell Medical College, Dr. Fisher was a robotic engineer before returning to Temple University, where he graduated Summa Cum Laude with a BA in Biology and Cognitive Neuroscience.

Dr. Fisher was a well-known Personal and Fitness trainer in Philadelphia. He Graduated from the MCP-Hahnemann School of Medicine in Philadelphia and completed his internship before moving to Texas. Upon completing his residency in Neurology and Fellowship in Movement Disorders at The University of Texas – Houston, Dr. Fisher combined his skills as a robotic engineer, fitness trainer and neurologist to do research in the use of robotically-assisted technology for neurological rehabilitation. He became a nationally recognized expert in the field of Neuromodulation, utilizing implantable devices for the treatment of Parkinson disease, tremor, dystonia as well as spasticity due to stroke, multiple sclerosis, traumatic brain and spinal cord injury.

Dr. Fisher is involved in clinical research related to psychosis and emotional lability in patients with neurodegenerative disorders. He has a strong interest in the field of Targeted Drug Delivery and Chairs an annual conference on the role of targeted drug delivery in the treatment of Pain and neurological Diseases.

For the past eight years he has served as a Program Director for Neurological Rehabilitation at the HealthSouth Center for Neurological Research and Recovery in Houston, TX, which includes four Acute Rehabilitation Hospitals in Houston Area. Currently he is a Program Director for Neurological Rehabilitation for Reliant Hospitals in Houston area.

This very special presentation is made possible by the generous sponsorship of Teva Pharmaceuticals.